Gauthier, Martin <br/><br/>
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.  [electronic resource] 

 -  BMC cancer  Aug 2019 
 - 809 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-019-5971-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin Variable Region--genetics<br/>Immunosuppressive Agents--adverse effects<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm, Residual<br/>Prognosis<br/>Rituximab--adverse effects<br/>Survival Analysis<br/>Treatment Outcome<br/>Vidarabine--adverse effects